Palisade Bio (PALI) Operating Income (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.68% |
| Dec 31, 2025 | -241.58% |
| Sep 30, 2025 | -2.78% |
| Jun 30, 2025 | -23.07% |
| Mar 31, 2025 | 31.70% |
| Dec 31, 2024 | 5.87% |
| Sep 30, 2024 | 14.68% |
| Jun 30, 2024 | -14.65% |
| Mar 31, 2024 | -16.46% |
| Dec 31, 2023 | 16.52% |
| Sep 30, 2023 | -4.68% |
| Jun 30, 2023 | -42.70% |
| Mar 31, 2023 | 34.28% |
| Dec 31, 2022 | 12.80% |
| Sep 30, 2022 | -23.54% |
| Jun 30, 2022 | 8.13% |
| Mar 31, 2022 | 3.45% |
| Dec 31, 2021 | -33.52% |
| Sep 30, 2021 | 90.82% |
| Jun 30, 2021 | -1,581.58% |
| Mar 31, 2021 | 39.78% |
| Dec 31, 2020 | -78.69% |
| Sep 30, 2020 | 1.36% |
| Jun 30, 2020 | 7.51% |
| Mar 31, 2020 | 6.66% |
| Dec 31, 2019 | -0.40% |
| Sep 30, 2019 | -10.73% |
| Jun 30, 2019 | 21.91% |
| Mar 31, 2019 | -36.11% |
| Dec 31, 2018 | 13.34% |
| Sep 30, 2018 | -2.95% |
| Jun 30, 2018 | 13.88% |
| Mar 31, 2018 | -3.53% |
| Dec 31, 2017 | 12.32% |
| Sep 30, 2017 | 38.65% |
| Jun 30, 2017 | 0.33% |
| Mar 31, 2017 | 25.12% |
| Dec 31, 2016 | -14.95% |
| Sep 30, 2016 | -28.24% |
| Jun 30, 2016 | 38.49% |
| Mar 31, 2016 | -43.26% |
| Dec 31, 2015 | 16.28% |
| Sep 30, 2015 | -4.06% |
| Jun 30, 2015 | -8.28% |
| Mar 31, 2015 | 0.60% |
| Dec 31, 2014 | -13.01% |
| Sep 30, 2014 | -16.96% |
| Jun 30, 2014 | 32.17% |
| Mar 31, 2014 | -87.39% |
| Dec 31, 2013 | 23.98% |
| Sep 30, 2013 | -12.31% |
| Jun 30, 2013 | -11.89% |
| Mar 31, 2013 | -6.05% |
| Dec 31, 2012 | -5.56% |
| Sep 30, 2012 | -8.39% |
| Jun 30, 2012 | 3.25% |
| Mar 31, 2012 | 3.86% |
| Dec 31, 2011 | 20.51% |
| Sep 30, 2011 | 12.15% |
| Jun 30, 2011 | -3.74% |
| Mar 31, 2011 | -2.53% |
| Dec 31, 2010 | 12.09% |
| Sep 30, 2010 | 6.47% |